Methotrexate impaired in-vivo matured mouse oocyte quality and the possible mechanisms
Abstract Background Methotrexate (MTX) is an antifolate agent which is widely used in clinic for treating malignancies, rheumatoid arthritis and ectopic pregnancy. As reported, MTX has side effects on gastrointestinal system, nervous system and reproductive system, while its potential damages on ooc...
Main Authors: | Ning Tian, Dan-yu Lv, Ji Yu, Wan-yun Ma |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2020-07-01
|
Series: | BMC Molecular and Cell Biology |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12860-020-00298-7 |
Similar Items
-
A Novel Method of Magnetic Nanoparticles Functionalized with Anti-Folate Receptor Antibody and Methotrexate for Antibody Mediated Targeted Drug Delivery
by: Madeeha Shahzad Lodhi, et al.
Published: (2022-01-01) -
Prenatal methotrexate injection increases behaviors possibly associated with depression and/or autism in rat offspring; A new animal model for mental disorder, based on folate metabolism deficit during pregnancy
by: Naoki Amada, et al.
Published: (2022-09-01) -
Paraquat Reduces the Female Fertility by Impairing the Oocyte Maturation in Mice
by: Yan-Li Sun, et al.
Published: (2021-02-01) -
New insights into methotrexate accumulation in leukemia cells in vivo
by: Elixabet Lopez-Lopez, et al.
Published: (2021-01-01) -
Role of pharmacogenetic factors in the development of side effects of methotrexate in the treatment of malignant tumors: A review
by: Timur T. Valiev, et al.
Published: (2021-12-01)